{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:01:16Z","timestamp":1790848876324,"version":"4.1.0"},"reference-count":178,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Apolipoprotein E4 (ApoE4) is the strongest genetic risk factor for Alzheimer\u2019s disease (AD), and ApoE4-directed gene editing and gene therapy have emerged as promising therapeutic strategies for AD, although they remain investigational and are not yet an established mainstream treatment. Interestingly, however, ApoE4 is reported to be associated with a reduced risk of retinal degenerative diseases such as glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy (DR). Therefore, should ApoE4 gene editing therapy be approached with caution when AD occurs concurrently with glaucoma, AMD, or DR? In view of these and based on the existing literature, the present study detailed the distinct roles of ApoE4 in AD, glaucoma, AMD, and DR, with a purpose to offer valuable insights into subsequent ApoE4 gene editing therapies. We also summarise the ApoE-targeted therapeutic programmes currently in preclinical and early clinical development, delineate the remaining translational challenges, and discuss how patients with coexisting retinal neurodegenerative disease might be evaluated and monitored.<\/jats:p>","DOI":"10.3389\/fneur.2026.1934307","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:39:19Z","timestamp":1790847559000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Should ApoE4 gene editing therapy be approached with caution when AD is accompanied by retinal neurodegenerative diseases?"],"prefix":"10.3389","volume":"17","author":[{"given":"Yi","family":"Wenhua","sequence":"first","affiliation":[{"name":"Chengdu Fifth People's Hospital","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma","family":"Wenjing","sequence":"additional","affiliation":[{"name":"Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Yan","sequence":"additional","affiliation":[{"name":"Chengdu Fifth People's Hospital","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Fei","sequence":"additional","affiliation":[{"name":"Chengdu Fifth People's Hospital","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Juan","sequence":"additional","affiliation":[{"name":"Chengdu Fifth People's Hospital","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tang","family":"Xia","sequence":"additional","affiliation":[{"name":"Chengdu Fifth People's Hospital","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan","family":"Yu","sequence":"additional","affiliation":[{"name":"Chengdu Fifth People's Hospital","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xin","sequence":"additional","affiliation":[{"name":"Chengdu Fifth People's Hospital","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang","family":"Yanlin","sequence":"additional","affiliation":[{"name":"Chengdu Fifth People's Hospital","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Ya","sequence":"additional","affiliation":[{"name":"Chengdu Fifth People's Hospital","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xuelin","sequence":"additional","affiliation":[{"name":"Chengdu Fifth People's Hospital","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luo","family":"Jing","sequence":"additional","affiliation":[{"name":"Chengdu Fifth People's Hospital","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Meimin","sequence":"additional","affiliation":[{"name":"Chengdu Fifth People's Hospital","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wenyi","sequence":"additional","affiliation":[{"name":"Chengdu Fifth People's Hospital","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Yilin","sequence":"additional","affiliation":[{"name":"Chengdu Fifth People's Hospital","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Hongke","sequence":"additional","affiliation":[{"name":"Chengdu Fifth People's Hospital","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yating","sequence":"additional","affiliation":[{"name":"Chengdu Fifth People's Hospital","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3934\/Neuroscience.2026009","article-title":"Alzheimer's disease: a comprehensive review of epidemiology, pathophysiology, diagnosis, and treatment","volume":"13","author":"Arachchige","year":"2026","journal-title":"AIMS Neurosci"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1177\/00912174251382653","article-title":"Depression and anxiety in patients with irreversible vision loss: Meta-analysis and systematic review","volume":"61","author":"Shah","year":"2026","journal-title":"Int J Psychiatry Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.3390\/jcm15093254","article-title":"Targeting neuroinflammation and oxidative stress to slow neurodegeneration in the visual system","volume":"15","author":"Shakaki","year":"2026","journal-title":"J Clin Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.immuni.2025.04.013","article-title":"Alzheimer's disease and age-related macular degeneration: shared and distinct immune mechanisms","volume":"58","author":"Butovsky","year":"2025","journal-title":"Immunity"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apolipoprotein E: cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/00041433-199906000-00003","article-title":"Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond","volume":"10","author":"Mahley","year":"1999","journal-title":"Curr Opin Lipidol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1086\/303070","article-title":"Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism","volume":"67","author":"Fullerton","year":"2000","journal-title":"Am J Hum Genet"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1074\/mcp.M900430-MCP200","article-title":"Glycosylation and sialylation of macrophage-derived human apolipoprotein E analyzed by SDS-PAGE and mass spectrometry: evidence for a novel site of glycosylation on Ser290","volume":"9","author":"Lee","year":"2010","journal-title":"Mol Cell Proteomics"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"104724","DOI":"10.1016\/j.nbd.2019.104724","article-title":"APOE in the normal brain","volume":"136","author":"Flowers","year":"2020","journal-title":"Neurobiol Dis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.neuron.2020.10.008","article-title":"Apolipoprotein E: structural insights and links to Alzheimer disease pathogenesis","volume":"109","author":"Chen","year":"2021","journal-title":"Neuron"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1126\/science.2063194","article-title":"Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E","volume":"252","author":"Wilson","year":"1991","journal-title":"Science"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0065-3233(08)60642-7","article-title":"Apolipoprotein E: structure-function relationships","volume":"45","author":"Weisgraber","year":"1994","journal-title":"Adv Protein Chem"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1515\/bc.2009.035","article-title":"Central nervous system: cholesterol turnover, brain development and neurodegeneration","volume":"390","author":"Dietschy","year":"2009","journal-title":"Biol Chem"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1021\/bi00727a022","article-title":"Heterogeneity of human plasma very low density lipoproteins. Separation of species differing in protein components","volume":"12","author":"Shore","year":"1973","journal-title":"Biochemistry"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1073\/pnas.70.7.2015","article-title":"Primary dysbetalipoproteinemia: predominance of a specific apoprotein species in triglyceride-rich lipoproteins","volume":"70","author":"Havel","year":"1973","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1001\/archneur.56.12.1484","article-title":"Preliminary observations on APOE epsilon4 allele and progression of disability in multiple sclerosis","volume":"56","author":"Chapman","year":"1999","journal-title":"Arch Neurol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.plipres.2011.06.002","article-title":"Cholesterol metabolism in neurons and astrocytes","volume":"50","author":"Pfrieger","year":"2011","journal-title":"Prog Lipid Res"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"5628","DOI":"10.1074\/jbc.271.10.5628","article-title":"Apolipoprotein E is synthesized in the retina by M\u00fcller glial cells, secreted into the vitreous, and rapidly transported into the optic nerve by retinal ganglion cells","volume":"271","author":"Amaratunga","year":"1996","journal-title":"J Biol Chem"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1167\/iovs.61.8.3","article-title":"Association of APOE with primary open-angle glaucoma suggests a protective effect for APOE \u03b54","volume":"61","author":"Margeta","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1167\/iovs.06-0902","article-title":"Stage-specific association of apolipoprotein A-I and E in developing mouse retina","volume":"48","author":"Kurumada","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref21","first-page":"1891","article-title":"Effects of cholesterol and apolipoprotein E on retinal abnormalities in ApoE-deficient mice","volume":"42","author":"Ong","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1076\/ceyr.27.2.15.15460","article-title":"Impaired electroretinogram (ERG) response in apolipoprotein E-deficient mice","volume":"27","author":"Ong","year":"2003","journal-title":"Curr Eye Res"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1172\/JCI112130","article-title":"Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system","volume":"76","author":"Boyles","year":"1985","journal-title":"J Clin Invest"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1523\/JNEUROSCI.5476-05.2006","article-title":"Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus","volume":"26","author":"Xu","year":"2006","journal-title":"J Neurosci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1006\/nbdi.1996.0023","article-title":"Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice","volume":"3","author":"Xu","year":"1996","journal-title":"Neurobiol Dis"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/MCO.0b013e32832182da","article-title":"Sterols in the central nervous system","volume":"12","author":"Mulder","year":"2009","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1172\/JCI200113992","article-title":"LRP: a multifunctional scavenger and signaling receptor","volume":"108","author":"Herz","year":"2001","journal-title":"J Clin Invest"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"8460","DOI":"10.1073\/pnas.93.16.8460","article-title":"Defective forebrain development in mice lacking gp330\/megalin","volume":"93","author":"Willnow","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0092-8674(00)80655-8","article-title":"An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3","volume":"96","author":"Nykjaer","year":"1999","journal-title":"Cell"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"18521","DOI":"10.1016\/s0021-9258(17)32340-2","article-title":"Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons","volume":"269","author":"Bu","year":"1994","journal-title":"J Biol Chem"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"8872","DOI":"10.1128\/MCB.24.20.8872-8883.2004","article-title":"Neuronal LRP1 functionally associates with postsynaptic proteins and is required for normal motor function in mice","volume":"24","author":"May","year":"2004","journal-title":"Mol Cell Biol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1242\/dev.01117","article-title":"LDL receptor-related proteins 5 and 6 in Wnt\/beta-catenin signaling: arrows point the way","volume":"131","author":"He","year":"2004","journal-title":"Development"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"14009","DOI":"10.1074\/jbc.M313828200","article-title":"Glial lipoproteins stimulate axon growth of central nervous system neurons in compartmented cultures","volume":"279","author":"Hayashi","year":"2004","journal-title":"J Biol Chem"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1523\/JNEUROSCI.5471-06.2007","article-title":"Apolipoprotein E-containing lipoproteins protect neurons from apoptosis via a signaling pathway involving low-density lipoprotein receptor-related protein-1","volume":"27","author":"Hayashi","year":"2007","journal-title":"J Neurosci"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"29605","DOI":"10.1074\/jbc.M109.039560","article-title":"Protection of neurons from apoptosis by apolipoprotein E-containing lipoproteins does not require lipoprotein uptake and involves activation of phospholipase Cgamma1 and inhibition of calcineurin","volume":"284","author":"Hayashi","year":"2009","journal-title":"J Biol Chem"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"25395","DOI":"10.1074\/jbc.M112.370130","article-title":"A potential neuroprotective role of apolipoprotein E-containing lipoproteins through low density lipoprotein receptor-related protein 1 in normal tension glaucoma","volume":"287","author":"Hayashi","year":"2012","journal-title":"J Biol Chem"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1074\/jbc.M110.151084","article-title":"Apolipoprotein E4 domain interaction mediates detrimental effects on mitochondria and is a potential therapeutic target for Alzheimer disease","volume":"286","author":"Chen","year":"2011","journal-title":"J Biol Chem"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s12035-015-9674-4","article-title":"Endogenous apolipoprotein E (ApoE) fragmentation is linked to amyloid pathology in transgenic mouse models of Alzheimer's disease","volume":"54","author":"Saul","year":"2017","journal-title":"Mol Neurobiol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1002\/ana.410340527","article-title":"The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease","volume":"34","author":"Mayeux","year":"1993","journal-title":"Ann Neurol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng0694-180","article-title":"Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease","volume":"7","author":"Corder","year":"1994","journal-title":"Nat Genet"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neuint.2006.07.007","article-title":"Convergence of genes implicated in Alzheimer's disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis","volume":"50","author":"Carter","year":"2007","journal-title":"Neurochem Int"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1111\/j.1471-4159.2004.02818.x","article-title":"Apolipoprotein E isoforms and apolipoprotein AI protect from amyloid precursor protein carboxy terminal fragment-associated cytotoxicity","volume":"91","author":"Maezawa","year":"2004","journal-title":"J Neurochem"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/mol.0b013e32833af368","article-title":"Mechanisms linking apolipoprotein E isoforms with cardiovascular and neurological diseases","volume":"21","author":"Huang","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3233\/jad-210549","article-title":"Race-related association between APOE genotype and Alzheimer's disease: a systematic review and meta-analysis","volume":"83","author":"Qin","year":"2021","journal-title":"J Alzheimer's Dis"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.neurobiolaging.2022.03.011","article-title":"ApoE4 reduction: an emerging and promising therapeutic strategy for Alzheimer's disease","volume":"115","author":"Li","year":"2022","journal-title":"Neurobiol Aging"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1007\/s12035-018-1237-z","article-title":"APOE and Alzheimer's disease: evidence mounts that targeting APOE4 may combat Alzheimer's pathogenesis","volume":"56","author":"Uddin","year":"2019","journal-title":"Mol Neurobiol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","article-title":"APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches","volume":"20","author":"Serrano-Pozo","year":"2021","journal-title":"Lancet Neurol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13024-015-0001-3","article-title":"Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and a\u03b2 metabolism in apoE4-targeted replacement mice","volume":"10","author":"Hu","year":"2015","journal-title":"Mol Neurodegener"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1089\/humc.2017.231","article-title":"AAVrh.10-mediated APOE2 central nervous system gene therapy for APOE4-associated Alzheimer's disease","volume":"29","author":"Rosenberg","year":"2018","journal-title":"Hum Gene Ther Clin Dev"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.arcmed.2017.08.002","article-title":"Association of Apolipoprotein E Polymorphisms with age-related macular degeneration subtypes: an updated systematic review and Meta-analysis","volume":"48","author":"Xiying","year":"2017","journal-title":"Arch Med Res"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1076\/opge.23.4.209.13883","article-title":"A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy","volume":"23","author":"Schmidt","year":"2002","journal-title":"Ophthalmic Genet"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1167\/iovs.03-1121","article-title":"The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration","volume":"45","author":"Baird","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1002\/humu.21577","article-title":"Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies","volume":"32","author":"McKay","year":"2011","journal-title":"Hum Mutat"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1471-2350-15-60","article-title":"Apolipoprotein E gene \u03b54\u03b54 is associated with elevated risk of primary open angle glaucoma in Asians: a meta-analysis","volume":"15","author":"Wang","year":"2014","journal-title":"BMC Med Genet"},{"key":"ref57","first-page":"1025","article-title":"An updated meta-analysis: apolipoprotein E genotypes and risk of primary open-angle glaucoma","volume":"20","author":"Liao","year":"2014","journal-title":"Mol Vis"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1016\/j.ijbiomac.2020.07.327","article-title":"Role of tau protein in Alzheimer's disease: the prime pathological player","volume":"163","author":"Muralidar","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"111893","DOI":"10.1016\/j.isci.2025.111893","article-title":"Imaging lipid rafts reveals the principle of ApoE4-induced a\u03b2 upregulation in human neurons","volume":"28","author":"Lee","year":"2025","journal-title":"iScience"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1093\/brain\/aws127","article-title":"Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-\u03b2","volume":"135","author":"Koffie","year":"2012","journal-title":"Brain"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2012.04.017","article-title":"Apolipoprotein E \u03b54 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease","volume":"34","author":"Fleisher","year":"2013","journal-title":"Neurobiol Aging"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.1093\/emboj\/cdf568","article-title":"The cytoplasmic domain of the LDL receptor-related protein regulates multiple steps in APP processing","volume":"21","author":"Pietrzik","year":"2002","journal-title":"EMBO J"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1172\/JCI124853","article-title":"APOE4-mediated amyloid-\u03b2 pathology depends on its neuronal receptor LRP1","volume":"129","author":"Tachibana","year":"2019","journal-title":"J Clin Invest"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.cell.2016.12.044","article-title":"ApoE2, ApoE3, and ApoE4 differentially stimulate APP transcription and a\u03b2 secretion","volume":"168","author":"Huang","year":"2017","journal-title":"Cell"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"102032","DOI":"10.1016\/j.pneurobio.2021.102032","article-title":"ApoE4 activates C\/EBP\u03b2\/\u03b4-secretase with 27-hydroxycholesterol, driving the pathogenesis of Alzheimer's disease","volume":"202","author":"Wang","year":"2021","journal-title":"Prog Neurobiol"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"15181","DOI":"10.1523\/JNEUROSCI.1542-12.2012","article-title":"Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid \u03b2 peptide","volume":"32","author":"Hashimoto","year":"2012","journal-title":"J Neurosci"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"13247","DOI":"10.1074\/jbc.RA117.001388","article-title":"A flow cytometry-based in vitro assay reveals that formation of apolipoprotein E (ApoE)-amyloid beta complexes depends on ApoE isoform and cell type","volume":"293","author":"Kara","year":"2018","journal-title":"J Biol Chem"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1471-2377-13-44","article-title":"The influence of apolipoprotein E genotype on regional pathology in Alzheimer's disease","volume":"13","author":"Sabbagh","year":"2013","journal-title":"BMC Neurol"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13195-020-00712-4","article-title":"APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer's disease: a systematic review","volume":"12","author":"Emrani","year":"2020","journal-title":"Alzheimer's Res Ther"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1038\/s41598-021-82901-1","article-title":"Astrocytic expression of the Alzheimer's disease risk allele, ApoE\u03b54, potentiates neuronal tau pathology in multiple preclinical models","volume":"11","author":"Jablonski","year":"2021","journal-title":"Sci Rep"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"e2108870119","DOI":"10.1073\/pnas.2108870119","article-title":"Astrocyte-secreted glypican-4 drives APOE4-dependent tau hyperphosphorylation","volume":"119","author":"Saroja","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"100715","DOI":"10.1016\/j.jbc.2021.100715","article-title":"Regulation of tau internalization, degradation, and seeding by LRP1 reveals multiple pathways for tau catabolism","volume":"296","author":"Cooper","year":"2021","journal-title":"J Biol Chem"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"12011","DOI":"10.1073\/pnas.0914984107","article-title":"ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling","volume":"107","author":"Chen","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/cns.12720","article-title":"Hippocampal synaptic and neural network deficits in young mice carrying the human APOE4 gene","volume":"23","author":"Sun","year":"2017","journal-title":"CNS Neurosci Ther"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/s41598-022-05225-8","article-title":"Little genomic support for cyclophilin A-matrix metalloproteinase-9 pathway as a therapeutic target for cognitive impairment in APOE4 carriers","volume":"12","author":"Anderson","year":"2022","journal-title":"Sci Rep"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ng0996-55","article-title":"Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides","volume":"14","author":"Miyata","year":"1996","journal-title":"Nat Genet"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/S0006-8993(01)03228-0","article-title":"Apolipoprotein E modulates Alzheimer's Abeta(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner","volume":"924","author":"Lauderback","year":"2002","journal-title":"Brain Res"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1034\/j.1600-0404.2000.102006346.x","article-title":"Relationship between oxidative stress and apoE phenotype in Alzheimer's disease","volume":"102","author":"Ihara","year":"2000","journal-title":"Acta Neurol Scand"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3233\/JAD-2011-110890","article-title":"Amyloid-\u03b2 toxicity and tau hyperphosphorylation are linked via RCAN1 in Alzheimer's disease","volume":"27","author":"Lloret","year":"2011","journal-title":"J Alzheimer's Dis"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.expneurol.2009.09.011","article-title":"GSK3: a possible link between beta amyloid peptide and tau protein","volume":"223","author":"Hern\u00e1ndez","year":"2010","journal-title":"Exp Neurol"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13578-021-00563-y","article-title":"ApoE4 (\u0394272-299) induces mitochondrial-associated membrane formation and mitochondrial impairment by enhancing GRP75-modulated mitochondrial calcium overload in neuron","volume":"11","author":"Liang","year":"2021","journal-title":"Cell Biosci"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"155298","DOI":"10.1016\/j.phymed.2023.155298","article-title":"A new andrographolide derivative ADA targeting SIRT3-FOXO3a signaling mitigates cognitive impairment by activating mitophagy and inhibiting neuroinflammation in Apoe4 mice","volume":"124","author":"Zhou","year":"2024","journal-title":"Phytomedicine"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"e70198","DOI":"10.1002\/alz.70198","article-title":"Genome-wide association analysis identifies APOE as a mitophagy modifier in Lewy body disease","volume":"21","author":"Hou","year":"2025","journal-title":"Alzheimers Dement"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s13578-022-00935-y","article-title":"FOXO3a-dependent PARKIN negatively regulates cardiac hypertrophy by restoring mitophagy","volume":"12","author":"Sun","year":"2022","journal-title":"Cell Biosci"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1750-1326-4-35","article-title":"Apolipoprotein E4 (1-272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells","volume":"4","author":"Nakamura","year":"2009","journal-title":"Mol Neurodegener"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/glia.22289","article-title":"APOE genotype alters glial activation and loss of synaptic markers in mice","volume":"60","author":"Zhu","year":"2012","journal-title":"Glia"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1750-3639.1998.tb00166.x","article-title":"Microglial activation in Alzheimer disease: association with APOE genotype","volume":"8","author":"Egensperger","year":"1998","journal-title":"Brain Pathol"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.neurobiolaging.2007.11.014","article-title":"APOE genotype-specific differences in the innate immune response","volume":"30","author":"Vitek","year":"2009","journal-title":"Neurobiol Aging"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3390\/cimb43010018","article-title":"Isoform-specific effects of apolipoprotein E on markers of inflammation and toxicity in brain glia and neuronal cells in vitro","volume":"43","author":"Iannucci","year":"2021","journal-title":"Curr Issues Mol Biol"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/MOL.0000000000000801","article-title":"Lipids and brain inflammation in APOE4-associated dementia","volume":"33","author":"Duro","year":"2022","journal-title":"Curr Opin Lipidol"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.bcp.2013.11.021","article-title":"TREM2 and the neuroimmunology of Alzheimer's disease","volume":"88","author":"Hickman","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.molmed.2017.03.008","article-title":"TREM2, microglia, and neurodegenerative diseases","volume":"23","author":"Yeh","year":"2017","journal-title":"Trends Mol Med"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.neuron.2022.10.022","article-title":"TREM2-independent microgliosis promotes tau-mediated neurodegeneration in the presence of ApoE4","volume":"111","author":"Gratuze","year":"2023","journal-title":"Neuron"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3233\/JAD-200958","article-title":"Apolipoprotein E \u025b4 (APOE \u025b4) allele is associated with Long sleep duration among elderly with cognitive impairment","volume":"79","author":"Basta","year":"2021","journal-title":"J Alzheimer's Dis"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2174\/1567205016666190103161034","article-title":"Abnormal sleep behaviours across the Spectrum of Alzheimer's disease severity: influence of APOE genotypes and Lewy bodies","volume":"16","author":"Koo","year":"2019","journal-title":"Curr Alzheimer Res"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1007\/s12640-021-00383-5","article-title":"Associations of sleep characteristics with cerebrospinal fluid sTREM2 in cognitively Normal older adults: the CABLE study","volume":"39","author":"Hu","year":"2021","journal-title":"Neurotox Res"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12916-019-1299-4","article-title":"ApoE4: an emerging therapeutic target for Alzheimer's disease","volume":"17","author":"Safieh","year":"2019","journal-title":"BMC Med"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13024-023-00610-x","article-title":"Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy","volume":"18","author":"Xiong","year":"2023","journal-title":"Mol Neurodegener"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline","volume":"581","author":"Montagne","year":"2020","journal-title":"Nature"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13024-021-00483-y","article-title":"APO\u03954 lowers energy expenditure in females and impairs glucose oxidation by increasing flux through aerobic glycolysis","volume":"16","author":"Farmer","year":"2021","journal-title":"Mol Neurodegener"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"e12006","DOI":"10.1002\/dad2.12006","article-title":"Interaction between APOE genotype and diabetes in cognitive decline","volume":"12","author":"Shinohara","year":"2020","journal-title":"Alzheimers Dement (Amst)"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S1474-4422(18)30251-5","article-title":"Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE \u03b54 haplotype status: a community-based cohort study","volume":"17","author":"Yang","year":"2018","journal-title":"Lancet Neurol"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1001\/jamaneurol.2018.3139","article-title":"Association of Apolipoprotein E \u03b54 with transactive response DNA-binding protein 43","volume":"75","author":"Wennberg","year":"2018","journal-title":"JAMA Neurol"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41593-021-00975-6","article-title":"TREM2 interacts with TDP-43 and mediates microglial neuroprotection against TDP-43-related neurodegeneration","volume":"25","author":"Xie","year":"2022","journal-title":"Nat Neurosci"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"100287","DOI":"10.1016\/j.xops.2023.100287","article-title":"No strong association between the apolipoprotein E E4 allele and Glaucoma: a multicohort study","volume":"3","author":"Mullany","year":"2023","journal-title":"Ophthalmol Sci"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ogla.2024.07.009","article-title":"Female-specific association between the apolipoprotein E E4 allele and age at diagnosis of Glaucoma in UK biobank","volume":"8","author":"Shi","year":"2025","journal-title":"Ophthalmol Glaucoma"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"100159","DOI":"10.1016\/j.xops.2022.100159","article-title":"The APOE E4 allele is associated with faster rates of Neuroretinal thinning in a prospective cohort study of suspect and early Glaucoma","volume":"2","author":"Mullany","year":"2022","journal-title":"Ophthalmol Sci"},{"key":"ref110","first-page":"389","article-title":"The apolipoprotein epsilon4 gene is associated with elevated risk of normal tension glaucoma","volume":"8","author":"Vickers","year":"2002","journal-title":"Mol Vis"},{"key":"ref111","first-page":"416","article-title":"A study on the association of apolipoprotein E genotypes with primary open-angle glaucoma and primary angle-closure glaucoma in northeast of China","volume":"43","author":"Yuan","year":"2007","journal-title":"Zhonghua Yan Ke Za Zhi"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1167\/iovs.64.14.33","article-title":"Association of APOE haplotypes with common age-related ocular diseases in 412,171 individuals","volume":"64","author":"Liuska","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/01.ijg.0000212217.19804.a7","article-title":"Association of apolipoprotein E polymorphisms with normal tension glaucoma in a Chinese population","volume":"15","author":"Lam","year":"2006","journal-title":"J Glaucoma"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.drudis.2017.11.004","article-title":"Galectin-3: mediator of microglia responses in injured brain","volume":"23","author":"Rahimian","year":"2018","journal-title":"Drug Discov Today"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.acthis.2012.11.010","article-title":"The pleiotropic effects of galectin-3 in neuroinflammation: a review","volume":"115","author":"Shin","year":"2013","journal-title":"Acta Histochem"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"10383","DOI":"10.1523\/JNEUROSCI.1498-12.2012","article-title":"Galectin-3 is required for resident microglia activation and proliferation in response to ischemic injury","volume":"32","author":"Lalancette-H\u00e9bert","year":"2012","journal-title":"J Neurosci"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.bbagen.2005.12.020","article-title":"Galectin-3: an open-ended story","volume":"1760","author":"Dumic","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1172\/JCI200317592","article-title":"Critical role of galectin-3 in phagocytosis by macrophages","volume":"112","author":"Sano","year":"2003","journal-title":"J Clin Invest"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00401-019-02013-z","article-title":"Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease","volume":"138","author":"Boza-Serrano","year":"2019","journal-title":"Acta Neuropathol"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.celrep.2015.02.012","article-title":"Microglia-secreted Galectin-3 acts as a toll-like receptor 4 ligand and contributes to microglial activation","volume":"10","author":"Burguillos","year":"2015","journal-title":"Cell Rep"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1002\/med.21784","article-title":"Microglia-derived galectin-3 in neuroinflammation; a bittersweet ligand?","volume":"41","author":"Rahimian","year":"2021","journal-title":"Med Res Rev"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/brb3.75","article-title":"Deletion of galectin-3 exacerbates microglial activation and accelerates disease progression and demise in a SOD1(G93A) mouse model of amyotrophic lateral sclerosis","volume":"2","author":"Lerman","year":"2012","journal-title":"Brain Behav"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.4049\/jimmunol.182.2.1167","article-title":"Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis","volume":"182","author":"Jiang","year":"2009","journal-title":"J Immunol"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"6371","DOI":"10.1007\/s12035-019-1527-0","article-title":"Delayed Galectin-3-mediated reprogramming of microglia after stroke is protective","volume":"56","author":"Rahimian","year":"2019","journal-title":"Mol Neurobiol"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1523\/JNEUROSCI.5360-06.2007","article-title":"Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain","volume":"27","author":"Lalancette-H\u00e9bert","year":"2007","journal-title":"J Neurosci"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"253","DOI":"10.14670\/HH-11-788","article-title":"Absence of galectin-3 promotes neuroprotection in retinal ganglion cells after optic nerve injury","volume":"32","author":"Abreu","year":"2017","journal-title":"Histol Histopathol"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.immuni.2022.07.014","article-title":"Apolipoprotein E4 impairs the response of neurodegenerative retinal microglia and prevents neuronal loss in glaucoma","volume":"55","author":"Margeta","year":"2022","journal-title":"Immunity"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1086\/301901","article-title":"Genetic association of apolipoprotein E with age-related macular degeneration","volume":"63","author":"Klaver","year":"1998","journal-title":"Am J Hum Genet"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/ng.3448","article-title":"A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants","volume":"48","author":"Fritsche","year":"2016","journal-title":"Nat Genet"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ophtha.2018.09.045","article-title":"Increased high-density lipoprotein levels associated with age-related macular degeneration: evidence from the EYE-RISK and European eye epidemiology consortia","volume":"126","author":"Colijn","year":"2019","journal-title":"Ophthalmology"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1167\/iovs.03-1253","article-title":"Association of apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single center","volume":"45","author":"Zareparsi","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: an update on pathobiology and treatment strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.neuron.2019.01.056","article-title":"A quarter century of APOE and Alzheimer's disease: Progress to date and the path forward","volume":"101","author":"Belloy","year":"2019","journal-title":"Neuron"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/sj.gene.6364289","article-title":"Qualitative and quantitative effects of APOE genetic variation on plasma C-reactive protein, LDL-cholesterol, and apoE protein","volume":"7","author":"Chasman","year":"2006","journal-title":"Genes Immun"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"211","DOI":"10.15252\/emmm.201404524","article-title":"Apolipoprotein E promotes subretinal mononuclear phagocyte survival and chronic inflammation in age-related macular degeneration","volume":"7","author":"Levy","year":"2015","journal-title":"EMBO Mol Med"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"13568","DOI":"10.1523\/JNEUROSCI.2468-15.2015","article-title":"APOE isoforms control pathogenic subretinal inflammation in age-related macular degeneration","volume":"35","author":"Levy","year":"2015","journal-title":"J Neurosci"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"25754","DOI":"10.1074\/jbc.m502143200","article-title":"The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP mice","volume":"280","author":"Fryer","year":"2005","journal-title":"J Biol Chem"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"e142254","DOI":"10.1172\/jci.insight.142254","article-title":"Mitochondria-dependent phase separation of disease-relevant proteins drives pathological features of age-related macular degeneration","volume":"6","author":"La Cunza","year":"2021","journal-title":"JCI Insight"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3109\/02713683.2015.1067325","article-title":"Association of Apolipoprotein E polymorphism with intravitreal ranibizumab treatment outcomes in age-related macular degeneration","volume":"41","author":"Bakbak","year":"2016","journal-title":"Curr Eye Res"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1016\/j.sjbs.2020.06.037","article-title":"APOE2 promotes the development and progression of subretinal neovascularization in age-related macular degeneration via MAPKs signaling pathway","volume":"27","author":"Sun","year":"2020","journal-title":"Saudi J Biol Sci"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0022-2275(20)38094-9","article-title":"Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes","volume":"23","author":"Zannis","year":"1982","journal-title":"J Lipid Res"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3233\/JAD-2011-101908","article-title":"Age-related macular degeneration (AMD): Alzheimer's disease in the eye?","volume":"24","author":"Kaarniranta","year":"2011","journal-title":"J Alzheimer's Dis"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/s0002-9394(99)80146-9","article-title":"The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration","volume":"125","author":"Souied","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"ref144","first-page":"2970","article-title":"The effect of age on the macromolecular permeability of human Bruch's membrane","volume":"42","author":"Moore","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.exer.2007.03.011","article-title":"Age-related changes in human macular Bruch's membrane as seen by quick-freeze\/deep-etch","volume":"85","author":"Huang","year":"2007","journal-title":"Exp Eye Res"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"key":"ref147","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/dme.12119","article-title":"Prevalence of diabetic retinopathy in type 2 diabetes in developing and developed countries","volume":"30","author":"Ruta","year":"2013","journal-title":"Diabet Med"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1001\/jamaophthalmol.2019.2536","article-title":"Diabetic retinal neurodegeneration-should we redefine retinopathy from diabetes?","volume":"137","author":"Sohn","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"E2655","DOI":"10.1073\/pnas.1522014113","article-title":"Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus","volume":"113","author":"Sohn","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref150","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.visres.2017.03.003","article-title":"Diabetic retinopathy is a neurodegenerative disorder","volume":"139","author":"Lynch","year":"2017","journal-title":"Vis Res"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1167\/iovs.17-21873","article-title":"Approach for a clinically useful comprehensive classification of vascular and neural aspects of diabetic retinal disease","volume":"59","author":"Abramoff","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"102415","DOI":"10.1016\/j.arr.2024.102415","article-title":"Navigating the intersection: diabetes and Alzheimer's intertwined relationship","volume":"100","author":"Kale","year":"2024","journal-title":"Ageing Res Rev"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"1065117","DOI":"10.3389\/fnagi.2022.1065117","article-title":"A combination of midlife diabetes mellitus and the apolipoprotein E \u03b54 allele increase risk for cognitive decline","volume":"14","author":"Lee","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"ref154","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ajo.2006.02.054","article-title":"Apolipoprotein E gene polymorphisms are not associated with diabetic retinopathy: the atherosclerosis risk in communities study","volume":"142","author":"Liew","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.1007\/s11033-021-06581-w","article-title":"The APOE4 allele is associated with a decreased risk of retinopathy in type 2 diabetics","volume":"48","author":"Dlouha","year":"2021","journal-title":"Mol Biol Rep"},{"key":"ref156","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1167\/iovs.16-20539","article-title":"Apolipoprotein E2 and E3, but not E4, promote retinal pathologic neovascularization","volume":"58","author":"Masuda","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref157","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1076\/opge.23.1.13.2203","article-title":"The epsilon4 allele of apolipoprotein E gene is a potential risk factor for the severity of macular edema in type 2 diabetic Mexican patients","volume":"23","author":"Santos","year":"2002","journal-title":"Ophthalmic Genet"},{"key":"ref158","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","article-title":"Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector","volume":"24","author":"Wang","year":"2018","journal-title":"Nat Med"},{"key":"ref159","doi-asserted-by":"publisher","first-page":"5253","DOI":"10.1074\/jbc.M111.276162","article-title":"Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons","volume":"287","author":"Chen","year":"2012","journal-title":"J Biol Chem"},{"key":"ref160","doi-asserted-by":"publisher","first-page":"17217","DOI":"10.1074\/jbc.M110.217380","article-title":"Structure-dependent impairment of intracellular apolipoprotein E4 trafficking and its detrimental effects are rescued by small-molecule structure correctors","volume":"286","author":"Brodbeck","year":"2011","journal-title":"J Biol Chem"},{"key":"ref161","doi-asserted-by":"publisher","first-page":"8997","DOI":"10.1021\/jm3008618","article-title":"Small-molecule structure correctors target abnormal protein structure and function: structure corrector rescue of apolipoprotein E4-associated neuropathology","volume":"55","author":"Mahley","year":"2012","journal-title":"J Med Chem"},{"key":"ref162","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/ana.26043","article-title":"Apolipoprotein E4 reduction with antisense oligonucleotides decreases neurodegeneration in a tauopathy model","volume":"89","author":"Litvinchuk","year":"2021","journal-title":"Ann Neurol"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.neuron.2017.11.014","article-title":"Age-dependent effects of apoE reduction using antisense oligonucleotides in a model of \u03b2-amyloidosis","volume":"96","author":"Huynh","year":"2017","journal-title":"Neuron"},{"key":"ref164","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1002\/alz.13703","article-title":"Silencing Apoe with divalent-siRNAs improves amyloid burden and activates immune response pathways in Alzheimer's disease","volume":"20","author":"Ferguson","year":"2024","journal-title":"Alzheimers Dement"},{"key":"ref165","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","article-title":"APOE4 causes widespread molecular and cellular alterations associated with Alzheimer's disease phenotypes in human iPSC-derived brain cell types","volume":"98","author":"Lin","year":"2018","journal-title":"Neuron"},{"key":"ref166","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1177\/10430342251401888","article-title":"Prime editing of Alzheimer's disease high-risk APOE4 allele by brain-directed adeno-associated virus vectors","volume":"37","author":"G\u00fcnaydin","year":"2026","journal-title":"Hum Gene Ther"},{"key":"ref167","doi-asserted-by":"publisher","first-page":"1304110","DOI":"10.3389\/fgeed.2024.1304110","article-title":"Epigenetic editing for autosomal dominant neurological disorders","volume":"6","author":"Waldo","year":"2024","journal-title":"Front Genome Ed"},{"key":"ref168","doi-asserted-by":"publisher","first-page":"e101538","DOI":"10.1002\/alz70859_101538","article-title":"Topline results from phase 1\/2 AAV gene therapy (LX1001) in APOE4\/4 homozygotes with Alzheimer\u2019s disease","volume":"21","author":"Johnson","year":"2025","journal-title":"Alzheimers Dement"},{"key":"ref169","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3233\/JAD-180422","article-title":"Neuro-Immuno-gene- and Genome-editing-therapy for Alzheimer's disease: are we there yet?","volume":"65","author":"Raikwar","year":"2018","journal-title":"J Alzheimer's Dis"},{"key":"ref170","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/s41591-024-02931-w","article-title":"APOE4 homozygosity represents a distinct genetic form of Alzheimer\u2019s disease","volume":"30","author":"Fortea","year":"2024","journal-title":"Nat Med"},{"key":"ref171","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1021\/acs.molpharmaceut.0c00461","article-title":"Design and validation of liposomal ApoE2 gene delivery system to evade blood-brain barrier for effective treatment of Alzheimer's disease","volume":"18","author":"Arora","year":"2021","journal-title":"Mol Pharm"},{"key":"ref172","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1007\/s13346-023-01482-w","article-title":"ApoE-functionalization of nanoparticles for targeted brain delivery-a feasible method for polyplexes?","volume":"14","author":"Hartl","year":"2024","journal-title":"Drug Deliv Transl Res"},{"key":"ref173","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1055\/s-2004-861492","article-title":"Apolipoprotein E and familial dysbetalipoproteinemia: clinical, biochemical, and genetic aspects","volume":"4","author":"Smelt","year":"2004","journal-title":"Semin Vasc Med"},{"key":"ref174","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s40265-024-02067-8","article-title":"Effects of Oral ALZ-801\/Valiltramiprosate on plasma biomarkers, brain hippocampal volume, and cognition: results of 2-year single-arm, open-label, phase 2 trial in APOE4 carriers with early Alzheimer's disease","volume":"84","author":"Hey","year":"2024","journal-title":"Drugs"},{"key":"ref175","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.trci.2019.04.001","article-title":"Enrichment factors for clinical trials in mild-to-moderate Alzheimer's disease","volume":"5","author":"Ballard","year":"2019","journal-title":"Alzheimers Dement (N Y)"},{"key":"ref176","doi-asserted-by":"publisher","first-page":"e12498","DOI":"10.1002\/trc2.12498","article-title":"APOLLOE4 phase 3 study of oral ALZ-801\/valiltramiprosate in APOE \u03b54\/\u03b54 homozygotes with early Alzheimer's disease: trial design and baseline characteristics","volume":"10","author":"Abushakra","year":"2024","journal-title":"Alzheimers Dement Transl Res Clin Interv"},{"key":"ref177","doi-asserted-by":"publisher","first-page":"112265","DOI":"10.1016\/j.isci.2025.112265","article-title":"The clinical safety landscape for ocular AAV gene therapies: a systematic review and meta-analysis","volume":"28","author":"Liu","year":"2025","journal-title":"iScience"},{"key":"ref178","doi-asserted-by":"publisher","first-page":"1799327","DOI":"10.3389\/fimmu.2026.1799327","article-title":"Intravitreal AAV vector delivery induces integrin-dependent ocular inflammation, complement activation, and antiviral and DNA damage responses","volume":"17","author":"Costa-Verdera","year":"2026","journal-title":"Front Immunol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1934307\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:39:21Z","timestamp":1790847561000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1934307\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":178,"alternative-id":["10.3389\/fneur.2026.1934307"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1934307","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"article-number":"1934307"}}